These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38551933)

  • 1. Bicyclomycin generates ROS and blocks cell division in Escherichia coli.
    Prakash A; Dutta D
    PLoS One; 2024; 19(3):e0293858. PubMed ID: 38551933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-gene deletion mutants of Escherichia coli with altered sensitivity to bicyclomycin, an inhibitor of transcription termination factor Rho.
    Tran L; van Baarsel JA; Washburn RS; Gottesman ME; Miller JH
    J Bacteriol; 2011 May; 193(9):2229-35. PubMed ID: 21357484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho.
    Riba I; Gaskell SJ; Cho H; Widger WR; Kohn H
    J Biol Chem; 1998 Dec; 273(51):34033-41. PubMed ID: 9852059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Biosynthesis of the Antibiotic Bicyclomycin in Distantly Related Bacterial Classes.
    Vior NM; Lacret R; Chandra G; Dorai-Raj S; Trick M; Truman AW
    Appl Environ Microbiol; 2018 May; 84(9):. PubMed ID: 29500259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis for the mode of action of bicyclomycin.
    Kohn H; Widger W
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage-Antibiotic Synergy via Delayed Lysis.
    Kim M; Jo Y; Hwang YJ; Hong HW; Hong SS; Park K; Myung H
    Appl Environ Microbiol; 2018 Nov; 84(22):. PubMed ID: 30217844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics.
    Malik M; Li L; Zhao X; Kerns RJ; Berger JM; Drlica K
    J Antimicrob Chemother; 2014 Dec; 69(12):3227-35. PubMed ID: 25085655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
    Zwiefka A; Kohn H; Widger WR
    Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.
    Skordalakes E; Brogan AP; Park BS; Kohn H; Berger JM
    Structure; 2005 Jan; 13(1):99-109. PubMed ID: 15642265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation.
    Bulssico J; PapukashvilI I; Espinosa L; Gandon S; Ansaldi M
    PLoS Pathog; 2023 Sep; 19(9):e1011602. PubMed ID: 37703280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
    Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
    Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho.
    Magyar A; Zhang X; Kohn H; Widger WR
    J Biol Chem; 1996 Oct; 271(41):25369-74. PubMed ID: 8810302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli.
    Rodríguez-Rosado AI; Valencia EY; Rodríguez-Rojas A; Costas C; Galhardo RS; Rodríguez-Beltrán J; Blázquez J
    J Antimicrob Chemother; 2019 Aug; 74(8):2188-2196. PubMed ID: 31102529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the bicyclomycin binding domain through biochemical analysis of antibiotic-resistant rho proteins.
    Magyar A; Zhang X; Abdi F; Kohn H; Widger WR
    J Biol Chem; 1999 Mar; 274(11):7316-24. PubMed ID: 10066795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of a comprehensive set of bicyclomycin-resistant mutants.
    Moyse KA; Knight JS; Richardson JP
    Biochim Biophys Acta; 2001 Sep; 1520(3):223-33. PubMed ID: 11566358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to abiotic surface induces SOS response in Escherichia coli K-12 strains under aerobic and anaerobic conditions.
    Costa SB; Campos ACC; Pereira ACM; de Mattos-Guaraldi AL; Júnior RH; Rosa ACP; Asad LMBO
    Microbiology (Reading); 2014 Sep; 160(Pt 9):1964-1973. PubMed ID: 25012969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.
    Carrano L; Bucci C; De Pascalis R; Lavitola A; Manna F; Corti E; Bruni CB; Alifano P
    Antimicrob Agents Chemother; 1998 Mar; 42(3):571-8. PubMed ID: 9517934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
    Moyse KA; Knight JS; Richardson JP
    J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E. coli.
    Cardinale CJ; Washburn RS; Tadigotla VR; Brown LM; Gottesman ME; Nudler E
    Science; 2008 May; 320(5878):935-8. PubMed ID: 18487194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Screen for
    Hu K; Artsimovitch I
    mBio; 2017 May; 8(3):. PubMed ID: 28559482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.